AHA: Icosapent Ethyl Cuts CV Risk From Elevated Triglycerides

TUESDAY, Nov. 13, 2018 -- Icosapent ethyl is associated with a reduced risk for ischemic events among patients with elevated triglyceride levels despite taking statins, according to a study published online Nov. 10 in the New England Journal of...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news